Herantis Pharma
1,43 EUR +1,78%4.041 investorer følger denne virksomhed
Omsætning
-
EBIT %
-
P/E
71,5
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Finland
HRTIS
Daglig lav / høj pris
1,4 / 1,46
EUR
Markedsværdi
28,83 mio. EUR
Aktieomsætning
45,67 t EUR
Volumen
32 t
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Skandinaviska Enskilda Banken | 18,6 % | 18,6 % |
Joensuun kauppa ja kone Oy | 9,8 % | 9,8 % |
Premium
This content is for our Premium customers only.
Insider transaktioner
Insider | Date | Total value |
---|---|---|
Tone Kvåle | 25.01.2024 | 7.500EUR |
Tone Kvåle | 01.06.2022 | 7.140EUR |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Herantis Pharma: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (19 April 2024)
Herantis Pharma participating at Finnish biotech and Investor meeting and at the Biotechgate Digital Partnering event
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools